COURTNEY WALL: Open Payments
NPI 1639796766 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 29 payments from 10 companies in 2025. Trend: 2023 $470 · 2024 $143 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $188 |
| Alkermes, Inc. | 2 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 1 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Vertical Pharmaceuticals, LLC | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $25 |
Products named: VRAYLAR, ARISTADA, Qelbree, UZEDY, CAPLYTA, REXULTI, SPRAVATO, COBENFY.
Industry payments across MO — which companies pay providers there.
